
Risk-On & Risk-Off Trades Get Hit… And Insmed CEO On Stock Surge 11/3/25
CNBC's "Fast Money"
00:00
Palantir Valuation Debate
Panel discusses Palantir's exceptional margins, heavy government revenue exposure, and concerns about 90+ times sales valuation.
Play episode from 24:14
Transcript


